<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="recently, pandemic (H1N1) 2009 virus resistance to oseltamivir emerged during" exact="treatment" post="of 2 immunosuppressed patients in the United States. Such"/>
 <result pre="United States and Europe in the 2007–08 influenza season, and" exact="prevalence" post="of such viruses has continued in 2009. The potential"/>
 <result pre="is unknown. Ecologic studies suggest a lack of association between" exact="prevalence" post="of oseltamivir use and prevalence of oseltamivir resistance (5)."/>
 <result pre="a lack of association between prevalence of oseltamivir use and" exact="prevalence" post="of oseltamivir resistance (5). However, examination of seasonal influenza"/>
 <result pre="a vaccine is available, combination antiviral therapy and rapid diagnostic" exact="testing" post="may be needed (7). Given the recently described low"/>
 <result pre="such assays to all patients is problematic (10). If rapid" exact="testing" post="has a role, it should be used in testing"/>
 <result pre="rapid testing has a role, it should be used in" exact="testing" post="persons at highest risk for developing influenza complications. However,"/>
 <result pre="of circulating strains is likely more appropriate than reliance on" exact="tests" post="with low sensitivity. Updated guidelines recently issued by the"/>
 <result pre="widely administered protective vaccine is needed to prevent transmission and" exact="infection" post="and preserve the efficacy of antiviral agents. Indiscriminant administration"/>
 <result pre="article: Hartley DM, Nelson NP, Perencevich EN. Antiviral drugs for" exact="treatment" post="of patients with pandemic (H1N1) 2009 virus [letter]. Emerg"/>
 <result pre="Disease Control and PreventionOseltamivir-resistant 2009 pandemic influenza A (H1N1) virus" exact="infection" post="in two summer campers receiving prophylaxis—North Carolina, 2009.MMWR Morb"/>
</results>
